Parth Desai

Parth is a Partner at Flare Capital Partners. Parth has a background in healthcare policy, operating, innovation and investing. At Flare Capital he is a lead/co-lead investor and Board Member at SmarterDx, Board Observer at Photon Health, Board Observer at Positive Development, Board Observer at BeMe Health and investor in Flare Scholar Ventures investments Birch AI (acquired by Sagility), Jaide Health, Rosarium Health and Helm Health. Parth also supports or has co-led Flare Capital’s investments into Aetion, HealthVerity and Suki AI. He previously supported Bright Health (IPO) and HealthReveal (acquired by Accolade). Additionally, Parth is a member of Boston University School of Public Health’s Advisory Committee and Alumni Leadership Council.

Prior to joining Flare Capital, Parth was an investor at NewYork-Presbyterian Hospital (NYP) Ventures, where he focused on applications of artificial intelligence to healthcare operations, leading investments into Saykara (acquired by Nuance), Syllable AI and Workfusion. In addition to venture investing, he also worked with the hospital’s executive leadership team to commercialize internal innovation and structure strategic partnerships to enhance the hospital’s patient and clinician care experience.

Prior to joining NYP Ventures, Parth was a health care strategy consultant at Deloitte Consulting, responsible for developing corporate growth strategies, advising M&A transactions and supporting operational transformations for leading providers, payers and technology companies. Parth began his career as health policy analyst for the Massachusetts House of Representatives, where he primarily worked with the Patrick administration to manage reform of the pharmaceutical compounding industry, authoring legislation signed into law by Governor Deval Patrick and used by the FDA to model national regulations.

Parth earned his BS in Biology from Boston College, MPH in Health Policy and Management from Boston University School of Public Health and Masters in Medicine from Boston University School of Medicine.